http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2127601-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86a607819dfc71863a2abf9405980338 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f07b8869692c91c2bd0af963b4c36d53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64fbf7f60cb7f53ed9f7ee620ceba1c2 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate | 1996-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a47153a0b4fa40f38e9df096d869efe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d897431546131d7bc5cbe88fcd9e513e |
| publicationDate | 1999-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2127601-C1 |
| titleOfInvention | Method of vaccination against diphtheria in children with system conjunctive tissue diseases |
| abstract | FIELD: pediatrics. SUBSTANCE: method is distinguished by that children in at least one-month remission phase are vaccinated with specified preparations on the background of anti- recurrence therapy, which is started 10 to 15 days before vaccination and resumed for 30 to 40 days after vaccination. EFFECT: enhanced vaccination efficiency and reduced risk of post-vaccination complications. 2 cl, 3 ex |
| priorityDate | 1996-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.